Men’s Health
-
Backing for ultrahypofractionated radiotherapy
Ultrahypofractionated radiotherapy is safe and effective for prostate cancer patients, a European conference will hear today. Read more
-
New drug targets for prostate cancer
Landmark research into prostate cancer has revealed 80 molecular ‘weaknesses’ that could be targeted by drugs, it was announced last night. Read more
-
Call for improved prostate testing as cancer cases missed
Urgent action is needed to find an effective way of screening for prostate cancer, campaigners and specialists say today. Read more
-
Men should be involved in breast cancer trials
A leading oncologist has called for men to be included in breast cancer trials to help improve treatments for the disease. Read more
-
How binge-watching puts men at risk
Men who binge-watch television face a significantly increased risk of developing colorectal cancer, according to the findings of a major UK analysis published today. Read more
-
Warning on health of single fathers
Single fathers who bring up children suffer significantly poorer health than other parents, researchers warn today. Read more
-
Man flu and Peppa Pig pose GP problems
It’s time to stop snivelling about men who claim to have "man flu" – researchers in Canada believe that the phenomenon could be real. Read more
-
AI to predict radiotherapy side-effects
A “big data” project is seeking to build a model that can predict the risk of side-effects from radiotherapy for prostate cancer, a conference will be told today. Read more
-
Male fertility concerns
Urgent action must be taken over the decline in male fertility in the Western world, an expert says today. Read more
-
PARP inhibitors show prostate care promise
PARP inhibitors may be the key to improving the effectiveness of prostate cancer treatment, researchers at Surrey University, UK, report today. Read more